Observe Medical

Carnegie Investment Bank Norway congratulates Observe Medical on their transformative acquisition of Biim Ultrasound, strengthening their global medtech platform.
 
Observe Medical has since their spin-off from Navamedic in 2019 had targeted M&A as a part of the growth agenda and will through the acquisition of Biim Ultrasound expand their product offering, extend their distribution network and extract operational synergies. The aim is to significantly accelerate the commercial roll-out of Sippi® in both Europe and the US. In parallel, Observe Medical’s network will be utilized to launch Biim on the European market.
 
Observe Medical is a Nordic-based medtech company focused on developing and commercialising proprietary and innovative medtech products to the global market through organic growth and targeted M&A. The company’s product, Sippi®, is the only automated digital urine meter with possibility for wireless data transfer to the hospital patient data management systems and hinders bacterial migration that can lead to urinary infections (SippCoat®).
 
Biim Ultrasound’s vision is to develop high quality, affordable point-of-care ultrasound imaging available to a broad range of trained medical professionals. The Company’s device, Biim, is a handheld, wireless, app-based ultrasound which puts the power of fast, flexible, cordless ultrasound in your hands – and in your pocket.
 
Carnegie acts as manager in the fully underwritten NOK 180 million rights issue where the use of proceeds will be to finance the cash portion of the acquisition consideration of Biim Ultrasound AS and for commercialisation and growth initiatives for Sippi® and Biim, repayment of current interest-bearing debt and general corporate purposes.
 
Thank you for the vote of confidence Terje Bakken, Björn Larsson, Per Arne Nygård, Eskild Endrerud and Rune Nystad